Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis.

Faure A, Hayes M, Sugden B.

Proc Natl Acad Sci U S A. 2019 Aug 13;116(33):16519-16528. doi: 10.1073/pnas.1905025116. Epub 2019 Jul 30.

2.

An Epigenetic Journey: Epstein-Barr Virus Transcribes Chromatinized and Subsequently Unchromatinized Templates during Its Lytic Cycle.

Chakravorty A, Sugden B, Johannsen EC.

J Virol. 2019 Apr 3;93(8). pii: e02247-18. doi: 10.1128/JVI.02247-18. Print 2019 Apr 15. Review.

3.

Long-distance communication: Looping of human papillomavirus genomes regulates expression of viral oncogenes.

Chakravorty A, Sugden B.

PLoS Biol. 2018 Nov 27;16(11):e3000062. doi: 10.1371/journal.pbio.3000062. eCollection 2018 Nov.

4.

Correction: Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally.

Chiu YF, Sugden AU, Fox K, Hayes M, Sugden B.

J Cell Biol. 2018 Oct 1;217(10):3766-3767. doi: 10.1083/JCB.20170201308082018c. Epub 2018 Aug 22. No abstract available.

5.

Plasmid Partitioning by Human Tumor Viruses.

Chiu YF, Sugden B.

J Virol. 2018 Apr 13;92(9). pii: e02170-17. doi: 10.1128/JVI.02170-17. Print 2018 May 1. Review.

6.

Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally.

Chiu YF, Sugden AU, Fox K, Hayes M, Sugden B.

J Cell Biol. 2017 Sep 4;216(9):2745-2758. doi: 10.1083/jcb.201702013. Epub 2017 Jul 10. Erratum in: J Cell Biol. 2018 Oct 1;217(10):3766-3767.

7.

Dissecting the regulation of EBV's BART miRNAs in carcinomas.

Yang YC, Liem A, Lambert PF, Sugden B.

Virology. 2017 May;505:148-154. doi: 10.1016/j.virol.2017.02.013. Epub 2017 Mar 1.

8.

Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.

Albanese M, Tagawa T, Bouvet M, Maliqi L, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Martin L, Moosmann A, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6467-E6475. Epub 2016 Oct 3.

9.

Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing.

Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, Zielinski C, Lutter D, Hoser J, Hastreiter M, Hayes M, Sugden B, Hammerschmidt W.

J Exp Med. 2016 Sep 19;213(10):2065-80. doi: 10.1084/jem.20160248. Epub 2016 Sep 12.

10.

Epstein-Barr Virus: The Path from Latent to Productive Infection.

Chiu YF, Sugden B.

Annu Rev Virol. 2016 Sep 29;3(1):359-372. Epub 2016 Aug 15. Review.

PMID:
27578440
11.

Using Organotypic Epithelial Tissue Culture to Study the Human Papillomavirus Life Cycle.

Lee D, Norby K, Hayes M, Chiu YF, Sugden B, Lambert PF.

Curr Protoc Microbiol. 2016 May 6;41:14B.8.1-14B.8.19. doi: 10.1002/cpmc.4.

12.

The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells.

Chakravorty A, Sugden B.

Virology. 2015 Oct;484:251-8. doi: 10.1016/j.virol.2015.05.018. Epub 2015 Jun 27.

13.

Epstein-Barr virus: the path from association to causality for a ubiquitous human pathogen.

Sugden B.

PLoS Biol. 2014 Sep 2;12(9):e1001939. doi: 10.1371/journal.pbio.1001939. eCollection 2014 Sep. No abstract available.

15.

Multiple functions are mediated by the miRNAs of Epstein-Barr virus.

Kuzembayeva M, Hayes M, Sugden B.

Curr Opin Virol. 2014 Aug;7:61-5. doi: 10.1016/j.coviro.2014.04.003. Epub 2014 May 10. Review.

16.

Epstein-Barr viral productive amplification reprograms nuclear architecture, DNA replication, and histone deposition.

Chiu YF, Sugden AU, Sugden B.

Cell Host Microbe. 2013 Dec 11;14(6):607-18. doi: 10.1016/j.chom.2013.11.009.

17.

Epstein-Barr virus maintains lymphomas via its miRNAs.

Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B.

Oncogene. 2014 Mar 6;33(10):1258-64. doi: 10.1038/onc.2013.71. Epub 2013 Mar 18.

18.

Potential cellular functions of Epstein-Barr Nuclear Antigen 1 (EBNA1) of Epstein-Barr Virus.

Westhoff Smith D, Sugden B.

Viruses. 2013 Jan 16;5(1):226-40. doi: 10.3390/v5010226. Review.

19.

Replication of Epstein-Barr viral DNA.

Hammerschmidt W, Sugden B.

Cold Spring Harb Perspect Biol. 2013 Jan 1;5(1):a013029. doi: 10.1101/cshperspect.a013029. Review.

20.

Monitoring plasmid replication in live mammalian cells over multiple generations by fluorescence microscopy.

Norby K, Chiu YF, Sugden B.

J Vis Exp. 2012 Dec 13;(70):e4305. doi: 10.3791/4305.

21.

Comparing proteomics and RISC immunoprecipitations to identify targets of Epstein-Barr viral miRNAs.

Kuzembayeva M, Chiu YF, Sugden B.

PLoS One. 2012;7(10):e47409. doi: 10.1371/journal.pone.0047409. Epub 2012 Oct 16.

22.

The ability of clinical tests to diagnose stress fractures: a systematic review and meta-analysis.

Schneiders AG, Sullivan SJ, Hendrick PA, Hones BD, McMaster AR, Sugden BA, Tomlinson C.

J Orthop Sports Phys Ther. 2012 Sep;42(9):760-71. doi: 10.2519/jospt.2012.4000. Epub 2012 Jul 19. Review.

PMID:
22813530
23.

Characterization and intracellular trafficking of Epstein-Barr virus BBLF1, a protein involved in virion maturation.

Chiu YF, Sugden B, Chang PJ, Chen LW, Lin YJ, Lan YC, Lai CH, Liou JY, Liu ST, Hung CH.

J Virol. 2012 Sep;86(18):9647-55. doi: 10.1128/JVI.01126-12. Epub 2012 Jun 27.

24.

The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells.

Pratt ZL, Zhang J, Sugden B.

J Virol. 2012 Apr;86(8):4380-93. doi: 10.1128/JVI.06966-11. Epub 2012 Feb 8.

25.

How human tumor viruses make use of autophagy.

Pratt ZL, Sugden B.

Cells. 2012 Aug 27;1(3):617-30. doi: 10.3390/cells1030617.

26.

Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes.

Dresang LR, Teuton JR, Feng H, Jacobs JM, Camp DG 2nd, Purvine SO, Gritsenko MA, Li Z, Smith RD, Sugden B, Moore PS, Chang Y.

BMC Genomics. 2011 Dec 20;12:625. doi: 10.1186/1471-2164-12-625.

27.

Lymphomas differ in their dependence on Epstein-Barr virus.

Vereide DT, Sugden B.

Blood. 2011 Feb 10;117(6):1977-85. doi: 10.1182/blood-2010-05-285791. Epub 2010 Nov 18.

28.

Insights into the evolution of lymphomas induced by Epstein-Barr virus.

Vereide D, Sugden B.

Adv Cancer Res. 2010;108:1-19. doi: 10.1016/B978-0-12-380888-2.00001-7. Review.

PMID:
21034964
29.

Proof for EBV's sustaining role in Burkitt's lymphomas.

Vereide D, Sugden B.

Semin Cancer Biol. 2009 Dec;19(6):389-93. doi: 10.1016/j.semcancer.2009.07.006. Epub 2009 Jul 21. Review.

30.

The microRNAs of Epstein-Barr Virus are expressed at dramatically differing levels among cell lines.

Pratt ZL, Kuzembayeva M, Sengupta S, Sugden B.

Virology. 2009 Apr 10;386(2):387-97. doi: 10.1016/j.virol.2009.01.006. Epub 2009 Feb 12.

31.
32.

The unfolded protein response and autophagy: herpesviruses rule!

Lee DY, Lee J, Sugden B.

J Virol. 2009 Feb;83(3):1168-72. doi: 10.1128/JVI.01358-08. Epub 2008 Sep 10. Review. No abstract available.

33.

EBV is necessary for proliferation of dually infected primary effusion lymphoma cells.

Mack AA, Sugden B.

Cancer Res. 2008 Sep 1;68(17):6963-8. doi: 10.1158/0008-5472.CAN-08-0627.

34.

Identifying a property of origins of DNA synthesis required to support plasmids stably in human cells.

Wang CY, Sugden B.

Proc Natl Acad Sci U S A. 2008 Jul 15;105(28):9639-44. doi: 10.1073/pnas.0801378105. Epub 2008 Jul 8.

35.

Reconfiguring the health supplier market: changing relationships in the primary care supplier market in England.

Sugden B, Wilson R, Cornford J.

Health Informatics J. 2008 Jun;14(2):113-24. doi: 10.1177/1081180X08089319.

PMID:
18477598
36.

MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins.

Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P.

Proc Natl Acad Sci U S A. 2008 Apr 15;105(15):5874-8. doi: 10.1073/pnas.0801130105. Epub 2008 Apr 4.

37.

The affinity of EBNA1 for its origin of DNA synthesis is a determinant of the origin's replicative efficiency.

Lindner SE, Zeller K, Schepers A, Sugden B.

J Virol. 2008 Jun;82(12):5693-702. doi: 10.1128/JVI.00332-08. Epub 2008 Apr 2.

38.
39.

The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy.

Lee DY, Sugden B.

Oncogene. 2008 May 1;27(20):2833-42. Epub 2007 Nov 26.

PMID:
18037963
40.

The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells.

Nanbo A, Sugden A, Sugden B.

EMBO J. 2007 Oct 3;26(19):4252-62. Epub 2007 Sep 13.

41.
42.

Comparison of P-POSSUM and O-POSSUM in predicting mortality after oesophagogastric resections.

Nagabhushan JS, Srinath S, Weir F, Angerson WJ, Sugden BA, Morran CG.

Postgrad Med J. 2007 May;83(979):355-8.

43.
44.

Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes.

Altmann M, Pich D, Ruiss R, Wang J, Sugden B, Hammerschmidt W.

Proc Natl Acad Sci U S A. 2006 Sep 19;103(38):14188-93. Epub 2006 Sep 11.

45.

Genome-wide expression profiling reveals EBV-associated inhibition of MHC class I expression in nasopharyngeal carcinoma.

Sengupta S, den Boon JA, Chen IH, Newton MA, Dahl DB, Chen M, Cheng YJ, Westra WH, Chen CJ, Hildesheim A, Sugden B, Ahlquist P.

Cancer Res. 2006 Aug 15;66(16):7999-8006.

46.

Virology: micro mystery solution.

Sugden B.

Nature. 2006 Jul 6;442(7098):33-4. No abstract available.

PMID:
16823440
47.

Essential elements of a licensed, mammalian plasmid origin of DNA synthesis.

Wang J, Lindner SE, Leight ER, Sugden B.

Mol Cell Biol. 2006 Feb;26(3):1124-34.

48.
49.

Lack of association between EBV and breast carcinoma.

Perrigoue JG, den Boon JA, Friedl A, Newton MA, Ahlquist P, Sugden B.

Cancer Epidemiol Biomarkers Prev. 2005 Apr;14(4):809-14.

50.

Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis.

Dirmeier U, Hoffmann R, Kilger E, Schultheiss U, BriseƱo C, Gires O, Kieser A, Eick D, Sugden B, Hammerschmidt W.

Oncogene. 2005 Mar 3;24(10):1711-7.

PMID:
15674340

Supplemental Content

Loading ...
Support Center